Department of Mental Health ASL Salerno, Mental Health Center Cava de' Tirreni, Salerno, Italy.
J Clin Psychopharmacol. 2011 Oct;31(5):625-32. doi: 10.1097/JCP.0b013e31822bb1ff.
The aim of this article was to analyze systematically literature information published in English (between 1966 and January 2011) on the efficacy of antidepressants in pediatric obsessive-compulsive disorder. Data were identified through different databases by using variously combined patterns of search terms. Searches provided 85 articles, excluding duplicates, but only articles reporting primary data on use of antidepressants in this specific disorder were reviewed. Fifty-nine articles were excluded because they did not report primary efficacy data or investigated patients with different psychiatric diagnosis. Twenty-five electronically recognized articles met the inclusion criteria. Two additional studies, available as congress communication, were identified by manually checking the references' list of electronically identified articles. Reviewed studies show several methodological biases (the lack/limited number of long-term trials and head-to-head comparisons and the inclusion of patients who continued different forms of psychotherapy), which make it difficult to individuate the best pharmacological strategy. Despite these limitations, evidence-based information suggests that clomipramine and sertraline, especially for long-term treatments, should be considered as first-choice agents for treating obsessive-compulsive disorder at onset during childhood or adolescence.
这篇文章的目的是系统分析 1966 年至 2011 年 1 月期间以英文发表的、关于抗抑郁药治疗儿科强迫症疗效的文献信息。通过不同数据库,采用不同组合的检索词进行了数据检索。检索提供了 85 篇文章,但只对报告了在这一特定障碍中使用抗抑郁药的原始数据的文章进行了综述。59 篇文章被排除,因为它们没有报告原始疗效数据,或者调查的是不同精神诊断的患者。25 篇电子确认的文章符合纳入标准。通过手动检查电子确认文章的参考文献列表,又确定了另外两项研究作为会议交流。综述研究显示出一些方法学上的偏见(缺乏/有限数量的长期试验和头对头比较,以及纳入继续接受不同形式心理治疗的患者),这使得很难确定最佳的药物治疗策略。尽管存在这些局限性,但基于证据的信息表明,氯米帕明和舍曲林,特别是在长期治疗方面,应该被认为是治疗儿童或青少年强迫症首发时的首选药物。